Ionis Pharma (IONS) Q3 Revenue Tops Views

Ionis Pharma (NASDAQ: IONS) reported Q3 EPS of $0.00, $0.01 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $120.9 million versus the consensus estimate of $116.96 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook